These structurally conserved mutations tend to cluster into specific mutational hotspots which may be shared by multiple kinase genes.
Both mutations tend to be proximal tumor location and mucinous histology, but KRAS-mutated tumors are more common in female patients.
Mutations tend to take place at a fairly constant rate over history.
The HA mutations tend to map to regions associated with receptor binding of the HA.
In contrast, secondary mutations tend to occur away from the nucleotide-binding pocket.
Rare blood types, which are expressions of mutations, tend to have characteristics singular to a particular part of the world.
Like behavioral and physical characteristics, those canine diseases and the responsible mutations tend to segregate according to breed, with many prone to more than one affliction.
By contrast, bigger life forms undergo long, complex cellular development in the embryo, in which random mutations tend to wreak havoc by introducing fatal abnormalities.
Fourth, and perhaps most intriguingly, driver mutations tend to be specific to individual paediatric cancer types, with minimal overlap across diseases.
Furthermore, research has shown that melanomas with NRAS mutations tend to be more aggressive and are more likely to develop resistance to treatment.
Previous reports (Wang et al., 2012) showed that disease-related mutations tend to be localized in domains linking to another protein (thereafter called "interface" domains).
